Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Donepezil hydrochloride may help lessen cognitive dysfunction caused by
chemotherapy.
PURPOSE: This phase II trial is studying donepezil hydrochloride in treating cognitive
dysfunction after chemotherapy in female breast cancer survivors.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest NCORP Research Base Wake Forest University Health Sciences